We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

174 hedge funds and large institutions have $1.52B invested in Acorda Therapeutics in 2014 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 63 increasing their positions, 58 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 20

60% more call options, than puts

Call options by funds: $13.3M | Put options by funds: $8.31M

7% more funds holding

Funds holding: 162 → 174 (+12)

9% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 58

3% more capital invested

Capital invested by funds: $1.47B → $1.52B (+$46.9M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
174
Holders Change
+12
Holders Change %
+7.41%
% of All Funds
5.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
32
Increased
63
Reduced
58
Closed
20
Calls
$13.3M
Puts
$8.31M
Net Calls
+$4.95M
Net Calls Change
+$6.72M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$42.2M
2
PHS
PFM Health Sciences
California
+$38.3M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$31.3M
4
VAM
Visium Asset Management
New York
+$16.6M
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$21M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$20.8M
3
BM
Bridger Management
New York
-$14.5M
4
Millennium Management
Millennium Management
New York
-$13.2M
5
Invesco
Invesco
Georgia
-$11.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$12.6M -$11.7M -3,112 -50%
Loomis, Sayles & Company
27
Loomis, Sayles & Company
Massachusetts
$12.2M +$11.2M +2,990 New
BA
28
BlackRock Advisors
Delaware
$12.1M -$6.14M -1,638 -36%
TA
29
Teachers Advisors
New York
$10.5M -$2.71M -723 -22%
T. Rowe Price Associates
30
T. Rowe Price Associates
Maryland
$10.5M +$11.3K +3 +0.1%
MACM
31
March Altus Capital Management
Connecticut
$10.3M +$2.09M +556 +28%
Millennium Management
32
Millennium Management
New York
$9.61M -$13.2M -3,515 -60%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$9.46M +$630K +168 +8%
TCM
34
Tekla Capital Management
Massachusetts
$9.26M +$1.48M +395 +21%
Principal Financial Group
35
Principal Financial Group
Iowa
$8.8M -$75K -20 -0.9%
AG
36
Artal Group
Luxembourg
$8.47M -$5.47M -1,459 -41%
RFC
37
Russell Frank Company
Washington
$8.11M +$2.48M +661 +50%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$8.06M +$161K +43 +2%
Goldman Sachs
39
Goldman Sachs
New York
$8M -$1.79M -476 -19%
TCIM
40
TIAA CREF Investment Management
New York
$7.41M -$105K -28 -2%
Bank of America
41
Bank of America
North Carolina
$7M +$158K +42 +3%
SFM
42
Sphera Funds Management
Israel
$6.75M +$1.53M +409 +33%
Ameriprise
43
Ameriprise
Minnesota
$6.64M -$3.38M -902 -36%
Macquarie Group
44
Macquarie Group
Australia
$6.24M +$1.27M +338 +28%
SGA
45
Sector Gamma AS
Norway
$5.98M -$6.19M -1,650 -53%
Prudential Financial
46
Prudential Financial
New Jersey
$5.46M -$3.04M -810 -38%
PAM
47
Panagora Asset Management
Massachusetts
$5.32M -$78.8K -21 -2%
BIM
48
BlackRock Investment Management
Delaware
$5.16M -$311K -83 -6%
GAM
49
Gotham Asset Management
New York
$5.1M +$3.11M +828 +194%
SO
50
STRS Ohio
Ohio
$5.09M -$263K -70 -5%
1
2
3 4 5

ACOR Hedge Fund Activity: Q3 2014 in Review

174 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2014, worth a combined $1.52B — up 3.2% from $1.47B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new ACOR positions and 20 closed out — a net gain of 12 holders — while 63 added to existing stakes and 58 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $42.2M. The largest seller was Citadel Advisors, cutting an estimated $21M.

  • 174 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2014, up from 162 in Q2 2014.
  • Funds reported $1.52B of Acorda Therapeutics stock for Q3 2014, up 3.2% quarter-over-quarter.
  • 32 funds opened new Acorda Therapeutics positions in Q3 2014 and 20 closed out, a net change of +12 holders.
  • The largest Acorda Therapeutics buyer in Q3 2014 was Fidelity Investments, an estimated $42.2M added.
  • The largest Acorda Therapeutics seller in Q3 2014 was Citadel Advisors, an estimated $21M sold.

Based on aggregated 13F filings for Q3 2014.